In mid-July, FDA Deputy Commissioner Howard Sklamberg posted an update on the implementation of FDASIA Title VII. In the post, he lists the progress FDA has made, such as rules, guidances, meetings, and reports related to protecting the global drug supply chain. Sklamberg covered similar ground at the FDLI forum on “Understanding CGMPs: What Attorneys Need to Know,” held at the Hogan Lovells law offices in Washington D.C. in mid-July.
[/membership][membership level=”0,4″][The content continues for paid members only.]
Login or Subscribe [/membership][membership level=”1,5,6,7,8,9,10,11,12″][membership]
